Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Heart Transplantation Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

4 recruiting trials for Heart Transplantation. Eligibility criteria explained in plain English.

TrialFinderData lists 4 Heart Transplantation clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Research is led by Fatebenefratelli Hospital (1), Hochgebirgsklinik Davos (1), IRCCS Azienda Ospedaliero-Universitaria di Bologna (1), among the most active sponsors registered for these trials.

The most frequently studied intervention is ABCDE-Stress Echo (diagnostic_test, 1 trial), followed by SE diastolic assessment, SE Right ventricular function assessment.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
4
Total Trials
4
Recruiting Now
0
Phase 3 Trials
4
Sponsors

Track Heart Transplantation trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT05081115

Stress Echo 2030: the Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging

With stress echo (SE) 2020 study, a new standard of practice in stress imaging was developed and disseminated: the ABCDE protocol for functional testing within and beyond CAD....

Sponsor: Fatebenefratelli HospitalEnrolling: 100001 location
RECRUITINGNCT07096973

Cardiac REhabilitation COhort at the Medicine Campus DaVos to invEstigate Recovery

The RECOVER study, titled Cardiac Rehabilitation Cohort at the Medicine Campus Davos for Exploration of Recovery, is a prospective, non-interventional, monocentric cohort study...

Sponsor: Hochgebirgsklinik DavosEnrolling: 100001 location
RECRUITINGNCT06813443

Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation

The study aims to identify new diagnostic and prognostic markers for CMP that can help predict disease progression. In particular, the study will focus on microRNAs (miRNAs) and...

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di BolognaEnrolling: 7003 locations
RECRUITINGNCT07359690

Multimodal Analysis of Endomyocardial Biopsies

The goal of this observational study is to pursue a multimodal approach to identify the molecular signatures and immune signalling molecules of various myocardial diseases and...

Sponsor: University Hospital, EssenEnrolling: 2161 location

Frequently Asked Questions

There are currently 4 clinical trials for Heart Transplantation, with 4 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Heart Transplantation, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Heart Transplantation, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.